Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-27T19:48:16.817Z Has data issue: false hasContentIssue false
  • English
  • Français

Immunological changes in a case of Marchiafava Bignami disease: response to amineptine treatment

Published online by Cambridge University Press:  16 April 2020

T Humbert ,
JP Bureau  and
P Chabrand
T Humbert
Affiliation:
Service de Psychiatrie, Hôpital d'Alès, 30100 Alés en Cévennes, France
JP Bureau
Affiliation:
Laboratoire de Biologie Cellulaire et d'Immunogénétique, Faculté de Médecine, 34000Montpellier, France
P Chabrand
Affiliation:
Service de Psychiatrie, Hôpital de Nîmes, 30000Nîmes, France
Get access

Summary

Marchiafava-Bignami disease (MBD) is a rare complication of chronic alcoholism. We describe a regressive form of MBD in which a primary decrease in CD4+ cells was improved by amineptine treatment. No significant change in the CD4 : CDS ratio was observed in a few major depressed subjects receiving this drug.

Keywords

Marchiafava-Bignami diseaseCD4+ CD8+ T cells HLA typingamineptine
Type
Case report
Information
European Psychiatry , Volume 10 , Issue 2 , 1995 , pp. 107 - 109
Copyright
Copyright © Elsevier, Paris 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alavi, AHirschj, LJStudies of central nervous system disorders with single-photon emission computed tomography and positron emission tomography: evolution over the past 2 decades Semin Nucl Med 21 1991; 58–81CrossRefGoogle ScholarPubMed
Bagasra, OForman, LFunctionnal analysis of lymphocyte subpopulations in experimental cocaine abuse. I. Dose dependent activation of lymphocyte subsets. Clin Exp Immunol 1989; 77: 289–93Google Scholar
Barnéoud, PNeveu, PJVitiello, SMormède, PLe Moal, MBrain neocortex immunomodulation in rats. Brain Res 1988; 474: 394–8CrossRefGoogle ScholarPubMed
Baron, RHeuser, KMarioth, GMarchiafava-Bignami disease with recovery diagnosed by CT and MRI: demyelisation affects several CNS structures. J Neurol 1989; 236: 364–6CrossRefGoogle Scholar
Bourrat, CTomassi, MBochu, MKopp, NMaisch, SX-ray scanning in Marchiafava-Bignami disease. Rev Neurol 1984; 140: 426–31Google ScholarPubMed
Delangre, TMannequin, DClavier, EDenis, PMihout, BSamson, MMaladie de Marchiafava-Bignami d'évolution favorable. Rev Neurol 1986; 142: 933–6Google Scholar
Delay, JBrion, SEscourolle, RSanchez, ARapports entre la dégénérescence du corps calleux de Marchiafava-Bignami et la sclérose laminaire corticale de Morel (à propos de 5 observations anatomo-cliniques). Encéphale 1959; 4: 281–311Google Scholar
De Micco, CToga, MLe statut immunitaire du système nerveux central. Rev Neurol 1988; 144: 776–88Google Scholar
Evans, DLPedersen, CAFolds, JDMajor depression and immunity: preliminary evidence of decreased natural killer cell populations Prog Neuropsycopharmacol Biol Psychiatry 12 1988 739–48CrossRefGoogle ScholarPubMed
Ferguson, RMSchmidtke, JRSimmons, RLBergsma, DGoldstein, ANeurochemical and Immunological Components of Schizophrenia 18 New York: Alan R Liss, 1978; 379–402Google Scholar
Heepe, PNemeth, LBrune, FGrant, JWKleihues, PMarchiafava-Bignami disease. A correlative computed tomography and morphological study. Eur Arch Psychiatr Neurol Sci 1988; 237: 74–910.1007/BF00382370CrossRefGoogle ScholarPubMed
Humbert, TDe Guilhermier, PMaktouf, CGrasset, GLopez, FMChabrand, PMarchiafava-Bignami disease. A case studied by structural and functional brain imaging. Eur Arch Psychiatry Clin Neurosci 1992; 242: 69–71CrossRefGoogle ScholarPubMed
Irwin, MCaldwell, CSmith, TLBrown, SSchuckit, MAGillin, JCMajor depressive disorder, alcoholism, and reduced natural killer cell cytotoxicity. Arch Gen Psychiatry 1990; 47: 713–9CrossRefGoogle ScholarPubMed
Kempinsky, WHExperimental study of distant effects of acute focal brain injury. A study of diaschisis. Arch Neurol Psychiatry 1958; 79: 376–89CrossRefGoogle ScholarPubMed
Leboyer, MOsherson, DNNosten, MRoubertoux, PIs autism associated with anomalous dominance?. J Autism Dev Disord 1988; 18: 539–4910.1007/BF02211872CrossRefGoogle ScholarPubMed
Marchiafava, EBignami, ASopra un alterzione del corpo calloso osservata in sogetti alcoolisti. Riv Patol Nerv Ment 1903; 8: 544–9Google Scholar
Meuer, SCSchlossmann, SFReinherz, ELClonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompa-tibility complex regions Proc Natl Acad Sci USA 79 1982; 4395–9CrossRefGoogle Scholar
Meyrignac, CBokobza, MCesaro, PDegos, JDContribution de l'image par résonance magnétique au diagnostic de la maladie de Marchiafava-Bignami. Presse Médicale 1987; 16: 1863–4Google Scholar
Neveu, PJCerebral neocortex modulation of immune functions. Life Sci 1988; 42: 1917–23CrossRefGoogle ScholarPubMed
Nevue, PJLatéralisation cérébrale et réponse immunitaire L'Encéphale XV 1989 405–8Google Scholar
Ou, DDShen, MLLuo, YDEffects of cocaine on the immune system of Balc/C mice. Clin Immunol Immunopathol 1989; 52: 305–12CrossRefGoogle Scholar
Schleifer, SJKeller, SEBond, RNCohen, JStein, MMajor depressive disorder and immunity. Arch Gen Psychiatry 1989; 46: 81–710.1001/archpsyc.1989.01810010083011CrossRefGoogle ScholarPubMed
Warren, RPMargaretten, NCPace, NCImmune abnormalities in patients with autism. J Autism Dev Disord 1986; 16: 189–9710.1007/BF01531729CrossRefGoogle ScholarPubMed
Wik, GBorg, SSjorgen, IPositron emission tomography determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose. Acta Psychiatr Scand 1988; 78: 234–41CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.